Nanomedicine: current status and future prospects
Abstract
Applications of nanotechnology for treatment, diagnosis, monitoring, and control of biological systems has recently been referred to as “nanomedicine” by the National Institutes of Health. Research into the rational delivery and targeting of pharmaceutical, therapeutic, and diagnostic agents is at the forefront of projects in nanomedicine. These involve the identification of precise targets (cells and receptors) related to specific clinical conditions and choice of the appropriate nanocarriers to achieve the required responses while minimizing the side effects. Mononuclear phagocytes, dendritic cells, endothelial cells, and cancers (tumor cells, as well as tumor neovasculature) are key targets. Today, nanotechnology and nanoscience approaches to particle design and formulation are beginning to expand the market for many drugs and are forming the basis for a highly profitable niche within the industry, but some predicted benefits are hyped. This article will highlight rational approaches in design and surface engineering of nanoscale vehicles and entities for site‐specific drug delivery and medical imaging after parenteral administration. Potential pitfalls or side effects associated with nanoparticles are also discussed.—Moghimi, S. M. Hunter, A. C., Murray, J. C. Nanomedicine: current status and future prospects. FASEB J. 19, 311‐330 (2005)
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Primary rationale of using a suitable drug delivery system is its ability to ensure higher and longer duration of drug bioavailability and thereby enhanced therapeutic efficacy.
“The primary rationale of using a suitable drug delivery system is its ability to ensure a higher and longer duration of drug bioavailability and thereby enhanced therapeutic efficacy.14,15”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [14]
Cites
In vivo cancer targeting and imaging with semiconductor quantum dots
Gao, X., Cui, Y., Levenson, R. M., Chung, L. W. K., & Nie, S. (2004) · Nature Biotechnology · doi:10.1038/nbt994 · Cited by 4,775 · see citing works
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552 · see citing works
Molecular Beacons: Probes that Fluoresce upon Hybridization
Tyagi, S., & Kramer, F. R. (1996) · Nature Biotechnology · doi:10.1038/nbt0396-303 · Cited by 4,164 · see citing works
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,521 · see citing works
Self-citationProbing the Cytotoxicity of Semiconductor Quantum Dots
Derfus, A. M., Chan, W. C. W., & Bhatia, S. N. (2003) · Nano Letters · doi:10.1021/nl0347334 · Cited by 3,394 · see citing works
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,365 · see citing works
Designing materials for biology and medicine
Langer, R., & Tirrell, D. A. (2004) · Nature · doi:10.1038/nature02388 · Cited by 3,198 · see citing works
In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles
Dubertret, B., Skourides, P., Norris, D. J., Noireaux, V., Brivanlou, A. H., & Libchaber, A. (2002) · Science · doi:10.1126/science.1077194 · Cited by 3,019 · see citing works
Wu, X., Liu, H., Liu, J., Haley, K. N., Treadway, J. A., Larson, J., Ge, N., Peale, F., & Bruchez, M. P. (2002) · Nature Biotechnology · doi:10.1038/nbt764 · Cited by 2,506 · see citing works
Water-Soluble Quantum Dots for Multiphoton Fluorescence Imaging in Vivo
Larson, D. R., Zipfel, W. R., Williams, R. M., Clark, S. W., Bruchez, M. P., Wise, F. W., & Webb, W. W. (2003) · Science · doi:10.1126/science.1083780 · Cited by 2,290 · see citing works
Selective Differentiation of Neural Progenitor Cells by High-Epitope Density Nanofibers
Silva, G. A., Czeisler, C. M., Niece, K. L., Beniash, E., Harrington, D. A., Kessler, J. A., & Stupp, S. I. (2004) · Science · doi:10.1126/science.1093783 · Cited by 2,169 · see citing works
The potential environmental impact of engineered nanomaterials
Colvin, V. L. (2003) · Nature Biotechnology · doi:10.1038/nbt875 · Cited by 2,161 · see citing works
Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping
Kim, S., Lim, Y. T., Soltesz, E. G., Grand, A. M. D., Lee, J., Nakayama, A., Parker, J. A., Mihaljevic, T., Laurence, R. G., Dor, D. M., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt920 · Cited by 2,087 · see citing works
Luminescent quantum dots for multiplexed biological detection and imaging
Chan, W. C. W., Maxwell, D. J., Gao, X., Bailey, R. E., Han, M., & Nie, S. (2002) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(02)00282-3 · Cited by 2,068 · see citing works
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. I. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,040 · see citing works
Long-term multiple color imaging of live cells using quantum dot bioconjugates
Jaiswal, J. K., Mattoussi, H. M., Mauro, J. M., & Simon, S. M. (2002) · Nature Biotechnology · doi:10.1038/nbt767 · Cited by 2,002 · see citing works
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., & Weissleder, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022749 · Cited by 1,971 · see citing works
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860 · see citing works
Genes Expressed in Human Tumor Endothelium
Croix, B. S., Rago, C., Velculescu, V. E., Traverso, G., Romans, K. E., Montgomery, E. A., Lal, A., Riggins, G. J., Christoph Lengauer, C., Vogelstein, B., et al. (2000) · Science · doi:10.1126/science.289.5482.1197 · Cited by 1,845 · see citing works
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature reviews. Cancer · doi:10.1038/nrc903 · Cited by 1,648 · see citing works
Wadia, J. S., Stan, R. V., & Dowdy, S. F. (2004) · Nature Medicine · doi:10.1038/nm996 · Cited by 1,647 · see citing works
Pharmacokinetics of Pegylated Liposomal Doxorubicin
Gabizón, A., Shmeeda, H., & Barenholz, Y. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00002 · Cited by 1,639 · see citing works
Nanosuspensions in drug delivery
Rabinow, B. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1494 · Cited by 1,528 · see citing works
Targeted drug delivery via the folate receptor
Sudimack, J. J., & Lee, R. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00062-9 · Cited by 1,477 · see citing works
Diffusion Dynamics of Glycine Receptors Revealed by Single-Quantum Dot Tracking
Dahan, M., Lévi, S., Luccardini, C., Rostaing, P., Riveau, B., & Triller, A. (2003) · Science · doi:10.1126/science.1088525 · Cited by 1,465 · see citing works
Richard, J., Melikov, K., Vivès, É., Ramos, C., Verbeure, B., Gait, M. J., Chernomordik, L., & Lebleu, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209548200 · Cited by 1,454 · see citing works
Åkerman, M. E., Chan, W. C. W., Laakkonen, P. M., Bhatia, S. N., & Ruoslahti, E. I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152463399 · Cited by 1,436 · see citing works
Bonifaz, L. C., Bonnyay, D., Mahnke, K., Rivera, M. N., Nussenzweig, M. C., & Steinman, R. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021598 · Cited by 1,306 · see citing works
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
Drummond, D. C., Meyer, O., Hong, K., Kirpotin, D. B., & Papahadjopoulos, D. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01426-1 · Cited by 1,265 · see citing works
Shvedova, A. A., Castranova, V., Kisin, E. R., Schwegler‐Berry, D., Murray, A. R., Gandelsman, V., Maynard, A., & Baron, P. A. (2003) · Journal of Toxicology and Environmental Health · doi:10.1080/713853956 · Cited by 1,245 · see citing works
Moghimi, S. M., & Szebeni, J. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00033-x · Cited by 1,228 · see citing works
Self-citationNanotech approaches to drug delivery and imaging
Sahoo, S. K., & Labhasetwar, V. D. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02903-9 · Cited by 1,208 · see citing works
Noninvasive Imaging of Quantum Dots in Mice
Ballou, B. T., Lagerholm, B. C., Ernst, L. A., Bruchez, M. P., & Waggoner, A. S. (2003) · Bioconjugate Chemistry · doi:10.1021/bc034153y · Cited by 1,141 · see citing works
Micellar Nanocontainers Distribute to Defined Cytoplasmic Organelles
Savić, R., Luo, L., Eisenberg, A., & Maysinger, D. (2003) · Science · doi:10.1126/science.1078192 · Cited by 1,113 · see citing works
Amphiphilic block copolymers for drug delivery
Adams, M. L., Lavasanifar, A., & Kwon, G. S. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10397 · Cited by 1,078 · see citing works
Panyam, J., Zhou, W., Prabha, S., Sahoo, S. K., & Labhasetwar, V. D. (2002) · The FASEB Journal · doi:10.1096/fj.02-0088com · Cited by 1,044 · see citing works
Introduction to Nanotechnology
(2003) · Materials Today · doi:10.1016/s1369-7021(03)00928-3 · Cited by 966 · see citing works
Dendritic cell immunotherapy: mapping the way
Figdor, C. G., de Vries, I. J. M., Lesterhuis, W. J., & Melief, C. J. M. (2004) · Nature Medicine · doi:10.1038/nm1039 · Cited by 940 · see citing works
Tumor Regression by Targeted Gene Delivery to the Neovasculature
Hood, J. D., Bednarski, M. D., Frausto, R. F., Guccione, S., Reisfeld, R. A., Xiang, R., & Cheresh, D. A. (2002) · Science · doi:10.1126/science.1070200 · Cited by 858 · see citing works
Cancer cells compress intratumour vessels
Padera, T. P., Stoll, B. R., Tooredman, J. B., Capen, D., Tomaso, E. D., & Jain, R. K. (2004) · Nature · doi:10.1038/427695a · Cited by 857 · see citing works
Kooi, M. E., Cappendijk, V. C., Cleutjens, K. B. J. M., Kessels, A. G. H., Kitslaar, P. J. E. H. M., Borgers, M., Frederik, P. M., Daemen, M. J. A. P., & van Engelshoven, J. M. A. (2003) · Circulation · doi:10.1161/01.cir.0000068315.98705.cc · Cited by 798 · see citing works
Endothelial cell diversity revealed by global expression profiling
Chi, J., Chang, H. Y., Haraldsen, G., Jahnsen, F. L., Troyanskaya, O. G., Chang, D. S., Wang, Z., Rockson, S. G., van de Rijn, M., Botstein, D., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1434429100 · Cited by 773 · see citing works
Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells
Anderson, D. G., Levenberg, S., & Langer, R. (2004) · Nature Biotechnology · doi:10.1038/nbt981 · Cited by 747 · see citing works
Liversidge, G. G., & Cundy, K. C. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00122-y · Cited by 741 · see citing works
Multifunctional nanorods for gene delivery
Salem, A. K., Searson, P. C., & Leong, K. W. (2003) · Nature Materials · doi:10.1038/nmat974 · Cited by 732 · see citing works
Gene therapy: trials and tribulations
Somia, N. V., & Verma, I. M. (2000) · Nature Reviews Genetics · doi:10.1038/35038533 · Cited by 711 · see citing works
Voura, E. B., Jaiswal, J. K., Mattoussi, H. M., & Simon, S. M. (2004) · Nature Medicine · doi:10.1038/nm1096 · Cited by 688 · see citing works
Quintana, A., Raczka, E., Piehler, L. T., Lee, I., Myc, A., Majoros, I., Patri, A. K., Thomas, T. P., Mulé, J. J., & Baker, J. R. (2002) · Pharmaceutical Research · doi:10.1023/a:1020398624602 · Cited by 664 · see citing works
Liposome application: problems and prospects.
Barenholz, Y. (2001) · Current Opinion in Colloid & Interface Science · doi:10.1016/s1359-0294(00)00090-x · Cited by 659 · see citing works
Eliceiri, B. P., & Cheresh, D. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6869 · Cited by 649 · see citing works
Kim, S., Bell, K. S., Mousa, S. A., & Varner, J. A. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65005-5 · Cited by 632 · see citing works
Steps toward mapping the human vasculature by phage display
Arap, W., Kolonin, M. G., Trepel, M., Lahdenranta, J., Cardó‐Vila, M., Giordano, R. J., Mintz, P. J., Ardelt, P., Yao, V. J., Vidal, C. I., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-121 · Cited by 606 · see citing works
Pluen, A., Boucher, Y., Ramanujan, S., McKee, T. D., Gohongi, T., di Tomaso, E., Brown, E. B., Izumi, Y., Campbell, R. B., Berk, D. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081626898 · Cited by 604 · see citing works
Ruehm, S. G., Corot, C., VOGT, P. R., Kolb, S., & Debatin, J. F. (2001) · Circulation · doi:10.1161/01.cir.103.3.415 · Cited by 600 · see citing works
Supramolecular Drug‐Delivery Systems Based on Polymeric Core–Shell Architectures
Haag, R. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200301694 · Cited by 589 · see citing works
Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs
Torchilin, V. P., Lukyanov, A. N., Gao, Z., & Papahadjopoulos‐Sternberg, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931428100 · Cited by 538 · see citing works
Anderson, D. G., Lynn, D. M., & Langer, R. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200351244 · Cited by 508 · see citing works
Singh, M., & O’Hagan, D. T. (1999) · Nature Biotechnology · doi:10.1038/15058 · Cited by 504 · see citing works
A tumor-homing peptide with a targeting specificity related to lymphatic vessels
Laakkonen, P. M., Porkka, K., Hoffman, J. A., & Ruoslahti, E. I. (2002) · Nature Medicine · doi:10.1038/nm720 · Cited by 500 · see citing works
Endocytosis and targeting of exogenous HIV‐1 Tat protein.
Mann, D. A., & Frankel, A. D. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07697.x · Cited by 485 · see citing works
Chanan-Khan, A., Szebeni, J., Savay, S., Liebes, L., Rafique, N. M., Alving, C. R., & Muggia, F. M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg374 · Cited by 479 · see citing works
Current status of pH-sensitive liposomes in drug delivery
Drummond, D. C., Zignani, M., & Leroux, J. (2000) · Progress in Lipid Research · doi:10.1016/s0163-7827(00)00011-4 · Cited by 478 · see citing works
Oh, P., Li, Y., Yu, J., Dürr, E., Krasinska, K. M., Carver, L. A., Testa, J. E., & Schnitzer, J. E. (2004) · Nature · doi:10.1038/nature02580 · Cited by 475 · see citing works
Kreuter, J., Ramge, P., Petrov, V. E., Hamm, S., Gelperina, S. E., Engelhardt, B., Alyautdin, R. N., von Briesen, H., & Begley, D. J. (2003) · Pharmaceutical Research · doi:10.1023/a:1022604120952 · Cited by 469 · see citing works
Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles
Steiniger, S. C. J., Kreuter, J., Khalansky, A. S., Skidan, I. N., Bobruskin, A. I., Smirnova, Z. S., Severin, E. S., Uhl, R., Kock, M., Geiger, K. D., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20048 · Cited by 434 · see citing works
Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome–DNA complexes
Torchilin, V. P., Levchenko, T. S., Rammohan, R., Volodina, N., Papahadjopoulos‐Sternberg, B., & D’Souza, G. G. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0435906100 · Cited by 419 · see citing works
Two-Color Labeling of Oligonucleotide Arrays via Size-Selective Scattering of Nanoparticle Probes
Taton, T. A., Lü, G., & Mirkin, C. A. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0102639 · Cited by 404 · see citing works
Goren, D., Horowitz, A. T., Tzemach, D., Tarshish, M., Zalipsky, S., & Gabizón, A. (2000) · PubMed · Cited by 402 · see citing works
Lynn, D. M., Anderson, D. G., Putnam, D. A., & Langer, R. (2001) · Journal of the American Chemical Society · doi:10.1021/ja016288p · Cited by 395 · see citing works
Winter, P. M., Caruthers, S. D., Kassner, A., Harris, T. D., Chinen, L. K., Allen, J. S., Lacy, E. K., Zhang, H., Robertson, J. D., Wickline, S. A., et al. (2003) · PubMed · Cited by 375 · see citing works
The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4
Hsu, L.-C., Park, J. M., Zhang, K., Luo, J., Maeda, S., Kaufman, R. J., Eckmann, L., Guiney, D. G., & Karin, M. (2004) · Nature · doi:10.1038/nature02405 · Cited by 357 · see citing works
Clark, H. A., Hoyer, M. E., Philbert, M. A., & Kopelman, R. (1999) · Analytical Chemistry · doi:10.1021/ac990629o · Cited by 355 · see citing works
Jain, R. K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00306-6 · Cited by 298 · see citing works
Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
Pastorino, F., Brignole, C., Marimpietri, D., Cilli, M., Gambini, C., Ribatti, D., Longhi, R., Allen, T. M., Corti, A., & Ponzoni, M. (2003) · PubMed · Cited by 296 · see citing works
Moving smaller in drug discovery and delivery
LaVan, D. A., Lynn, D. M., & Langer, R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd707 · Cited by 287 · see citing works
Use of magnetic nanoparticles as nanosensors to probe for molecular interactions
Perez, J. M., Josephson, L., & Weissleder, R. (2004) · ChemBioChem · doi:10.1002/cbic.200300730 · Cited by 268 · see citing works
Gene transfer with modified polyethylenimines
Kichler, A. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.507 · Cited by 266 · see citing works
Zitzmann, S., Ehemann, V., & Schwab, M. (2002) · PubMed · Cited by 265 · see citing works
Cavazzana, M., Thrasher, A. J., & Mavilio, F. (2004) · Nature · doi:10.1038/427779a · Cited by 263 · see citing works
Batrakova, E. V., Li, S., Alakhov, V. Y., Miller, D. W., & Kabanov, A. V. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.043307 · Cited by 263 · see citing works
Diacyllipid-Polymer Micelles as Nanocarriers for Poorly Soluble Anticancer Drugs
Gao, Z., Lukyanov, A. N., Singhal, A., & Torchilin, V. P. (2002) · Nano Letters · doi:10.1021/nl025604a · Cited by 262 · see citing works
Non-viral and hybrid vectors in human gene therapy: an update
Schmidt‐Wolf, G., & Schmidt‐Wolf, I. G. H. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00005-4 · Cited by 253 · see citing works
Dendritic Molecular Capsules for Hydrophobic Compounds
Morgan, M. T., Carnahan, M. A., Immoos, C. E., Ribeiro, A. A., Finkelstein, S., Lee, S. J., & Grinstaff, M. W. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0347383 · Cited by 252 · see citing works
Oh, K. T., Bronich, T. K., & Kabanov, A. V. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.10.018 · Cited by 250 · see citing works
Sapra, P., & Allen, T. M. (2002) · PubMed · Cited by 242 · see citing works
Depletion of macrophages reduces axonal degeneration and hyperalgesia following nerve injury
Liu, T., van Rooijen, N., & Tracey, D. J. (2000) · Pain · doi:10.1016/s0304-3959(99)00306-1 · Cited by 241 · see citing works
Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration
Curnis, F., Sacchi, A., & Corti, A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15223 · Cited by 238 · see citing works
Wickham, T. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301115 · Cited by 236 · see citing works
In vivo MRI of brain inflammation in human ischaemic stroke
Saleh, A., Schroeter, M., Jonkmanns, C., Hartung, H., Mödder, U., & Jander, S. (2004) · Brain · doi:10.1093/brain/awh191 · Cited by 228 · see citing works
Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration
Curnis, F., Sacchi, A., & Corti, A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215223 · Cited by 228 · see citing works
King, M., Su, W. T., Chang, A., et al. (2001) · Nature Neuroscience · doi:10.1038/85115 · Cited by 211 · see citing works
Wolff, G., Worgall, S., van Rooijen, N., Song, W., Harvey, B., & Crystal, R. G. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.624-629.1997 · Cited by 210 · see citing works
Hybrid Virus−Polymer Materials. 1. Synthesis and Properties of PEG-Decorated Cowpea Mosaic Virus
Raja, K. S., Wang, Q., González, M. J., et al. (2003) · Biomacromolecules · doi:10.1021/bm025740+ · Cited by 205 · see citing works
Probing the structural and molecular diversity of tumor vasculature
Pasqualini, R., Arap, W., & McDonald, D. M. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02429-2 · Cited by 205 · see citing works
Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice
McLean, J. W., Fox, E. A., Bałuk, P., Bolton, P. B., Haskell, A., Pearlman, R., Thurston, G., Umemoto, E. Y., & McDonald, D. M. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.273.1.h387 · Cited by 199 · see citing works
Self-assembling complexes for gene delivery : from laboratory to clinical trial
Kabanov, A. V., Felgner, P. L., & Seymour, L. W. (1998) · Cited by 198 · see citing works
Panyam, J., & Labhasetwar, V. D. (2003) · Molecular Pharmaceutics · doi:10.1021/mp034002c · Cited by 195 · see citing works
Jaffer, F. A., & Weissleder, R. (2004) · Circulation Research · doi:10.1161/01.res.0000119321.18573.5a · Cited by 193 · see citing works
Inflexal®V a trivalent virosome subunit influenza vaccine: production
Mischler, R., & Metcalfe, I. C. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00512-1 · Cited by 183 · see citing works
Porter, C. J. H., Moghimi, S. M., Illum, L., & Davis, S. S. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80655-z · Cited by 173 · see citing works
Self-citationMoghimi, S. M., & Hunter, A. C. (2001) · Pharmaceutical Research · doi:10.1023/a:1011054123304 · Cited by 161 · see citing works
Self-citationMcIntyre, J. O., Fingleton, B., Wells, K. S., et al. (2004) · Biochemical Journal · doi:10.1042/bj20030582 · Cited by 160 · see citing works
Andresen, T. L., Davidsen, J. R., Begtrup, M., Mouritsen, O. G., & Jørgensen, K. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031029r · Cited by 158 · see citing works
Solution Structures and Integrin Binding Activities of an RGD Peptide with Two Isomers
Assa‐Munt, N., Jia, X., Laakkonen, P. M., & Ruoslahti, E. I. (2001) · Biochemistry · doi:10.1021/bi002101f · Cited by 157 · see citing works
Muro, S., Cui, X., Gajewski, C., et al. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00099.2003 · Cited by 153 · see citing works
Omidi, Y., Hollins, A. J., Benboubetra, M., Drayton, R. M., Benter, I. F., & Akhtar, S. (2003) · Journal of drug targeting · doi:10.1080/10611860310001636908 · Cited by 152 · see citing works
Gbadamosi, J. K., Hunter, A. C., & Moghimi, S. M. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03710-9 · Cited by 150 · see citing works
Self-citationCationic Lipid Vectors for Plasmid DNA Delivery
Hirko, A. C., Tang, F., & Hughes, J. A. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457412 · Cited by 150 · see citing works
Metselaar, J. M., van den Berg, W. B., Holthuysen, A. E. M., Wauben, M. H. M., Storm, G., & van Lent, P. L. E. M. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.009944 · Cited by 149 · see citing works
Szebeni, J., Alving, C. R., Sávay, S., Barenholz, Y., Priev, A., Danino, D., & Talmon, Y. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00006-6 · Cited by 145 · see citing works
Lighting Up Cells with Quantum Dots
Watson, A., Wu, X., & Bruchez, M. P. (2003) · BioTechniques · doi:10.2144/03342bi01 · Cited by 143 · see citing works
Szebeni, J. (2001) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v18.i6.50 · Cited by 143 · see citing works
Dousset, V., Ballarino, L., Delalande, C., et al. (1999) · PubMed · Cited by 143 · see citing works
Bandak, S., Goren, D., Horowitz, A. T., et al. (1999) · Anti-Cancer Drugs · doi:10.1097/00001813-199911000-00007 · Cited by 138 · see citing works
Davidsen, J. R., Jørgensen, K., Andresen, T. L., & Mouritsen, O. G. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00659-4 · Cited by 138 · see citing works
Kabanov, A. V. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00211-6 · Cited by 137 · see citing works
Moghimi, S. M. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00099-4 · Cited by 135 · see citing works
Self-citationTuftsin-bearing liposomes in treatment of macrophage-based infections
Agrawal, A. K., & Gupta, C. M. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00061-7 · Cited by 134 · see citing works
Muzykantov, V. R., Christofidou‐Solomidou, M., Balyasnikova, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2379 · Cited by 130 · see citing works
Ran, S., Gao, B., Duffy, S. L., Watkins, L. R., Rote, N., & Thorpe, P. E. (1998) · PubMed · Cited by 128 · see citing works
Braet, F., Zanger, R. D., Baekeland, M., Crabbé, E., Smissen, P. V. D., & Wisse, E. (1995) · Hepatology · doi:10.1002/hep.1840210130 · Cited by 128 · see citing works
Reid, D. M., Montoya, M., Taylor, P. R., Borrow, P., Gordon, S., Brown, G. D., & Wong, S. Y. C. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0104031 · Cited by 128 · see citing works
Moghimi, S. M., Hunter, A. C., Dadswell, C., Sávay, S., Alving, C. R., & Szebeni, J. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.02.005 · Cited by 120 · see citing works
Self-citationAberrant vascular architecture in tumors and its importance in drug-based therapies
Munn, L. L. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02686-2 · Cited by 119 · see citing works
Biophysical mechanisms of phospholipase A2 activation and their use in liposome‐based drug delivery
Jørgensen, K., Davidsen, J. R., & Mouritsen, O. G. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03408-7 · Cited by 116 · see citing works
Krämer, M., Stumbé, J., Grimm, G. N., et al. (2004) · ChemBioChem · doi:10.1002/cbic.200300905 · Cited by 112 · see citing works
pDMAEMA is internalised by endocytosis but does not physically disrupt endosomes
Jones, R. A., Poniris, M. H., & Wilson, M. R. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.02.011 · Cited by 111 · see citing works
The effect of phagocytosis of poly( L ‐lactic acid) fragments on cellular morphology and viability
Lam, K. H., Schakenraad, J. M., Esselbrugge, H., Feijén, J., & Nieuwenhuis, P. (1993) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820271214 · Cited by 109 · see citing works
Microparticles and Nanoparticles as Delivery Systems for DNA Vaccines
Cui, Z., & Mumper, R. J. (2003) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v20.i23.10 · Cited by 105 · see citing works
Haviv, Y. S., Blackwell, J. L., Kanerva, A., Nagi, P. A., Krasnykh, V. N., Dmitriev, I. P., Wang, M., Naito, S., Lei, X., Hemminki, A., et al. (2002) · Molecular Therapy · doi:10.1016/s1525-0016(16)44194-8 · Cited by 104 · see citing works
Moghimi, S. M. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00204-5 · Cited by 103 · see citing works
Self-citationBlock Copolymer Micelles for the Encapsulation and Delivery of Amphotericin B
Lavasanifar, A., Samuel, J., Sattari, S., & Kwon, G. S. (2002) · Pharmaceutical Research · doi:10.1023/a:1015127225021 · Cited by 96 · see citing works
Drug targeting to specific vascular sites
Ruoslahti, E. I. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02501-1 · Cited by 90 · see citing works
Application of Nanoparticle Technology for the Prevention of Restenosis After Balloon Injury in Rats
Uwatoku, T., Shimokawa, H., Abe, K., Matsumoto, Y., Hattori, T., Oi, K., Matsuda, T., Kataoka, K., & Takeshita, A. (2003) · Circulation Research · doi:10.1161/01.res.0000069021.56380.e2 · Cited by 88 · see citing works
MR imaging of murine arthritis using ultrasmall superparamagnetic iron oxide particles☆
Dardzinski, B. J., Schmithorst, V. J., Holland, S. K., et al. (2001) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(01)00448-9 · Cited by 87 · see citing works
Therapeutic synthetic polymers: a game of Russian roulette?
Hunter, A. C., & Moghimi, S. M. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02444-3 · Cited by 83 · see citing works
Self-citationLong-circulating vectors for the systemic delivery of genes.
Fenske, D. B., MacLachlan, I., & Cullis, P. R. (2001) · PubMed · Cited by 82 · see citing works
Micelles from polyethylene glycol/phosphatidylethanolamine conjugates for tumor drug delivery
Lukyanov, A. N. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00217-7 · Cited by 78 · see citing works
Optical nanosensors for chemical analysis inside single living *cells.
Clark, H. A. (1999) · Deep Blue (University of Michigan) · Cited by 78 · see citing works
Synergistic permeability enhancing effect of lysophospholipids and fatty acids on lipid membranes
Davidsen, J. R., Mouritsen, O. G., & Jørgensen, K. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00461-3 · Cited by 75 · see citing works
Alves‐Rosa, F., Stanganelli, C., Cabrera, J., van Rooijen, N., Palermo, M. S., & Isturiz, M. A. (2000) · Blood · doi:10.1182/blood.v96.8.2834 · Cited by 74 · see citing works
Moghimi, S. M. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00273-4 · Cited by 72 · see citing works
Self-citationNovel Method of Greatly Enhanced Delivery of Liposomes to Lymph Nodes
Phillips, W. T., Klipper, R. W., & Goins, B. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38903-7 · Cited by 71 · see citing works
Danenberg, H. D., Fishbein, I., Epstein, H., et al. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200311000-00014 · Cited by 71 · see citing works
Dileo, J., Banerjee, R., Whitmore, M., et al. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00064-9 · Cited by 69 · see citing works
Wu, G. S., Korsgren, O., Zhang, J., et al. (2000) · Xenotransplantation · doi:10.1034/j.1399-3089.2000.00071.x · Cited by 69 · see citing works
Lipid-based formulations of amphotericin B
Veerareddy, P. R., & Vobalaboina, V. (2004) · Drugs of today · doi:10.1358/dot.2004.40.2.799425 · Cited by 68 · see citing works
pH-Triggered Microparticles for Peptide Vaccination
Haining, W. N., Anderson, D. G., Little, S. R., von Berwelt-Baildon, M. S., Cardoso, A. A., Alves, P. M. S., Kosmatopoulos, K., Nadler, L. M., Langer, R., & Kohane, D. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2578 · Cited by 68 · see citing works
Cellular Distribution of Nonionic Micelles
Moghimi, S. M., Hunter, A. C., Murray, J. C., & Szewczyk, A. M. (2004) · Science · doi:10.1126/science.303.5658.626 · Cited by 61 · see citing works
Self-citationScherpereel, A., Wiewrodt, R. G., Christofidou‐Solomidou, M., et al. (2001) · The FASEB Journal · doi:10.1096/fj.00-0022com · Cited by 56 · see citing works
Targeting dendritic cells for priming cellular immune responses
Gogolák, P., Réthi, B., Hajas, G., & Rajnavölgyi, É. (2003) · Journal of Molecular Recognition · doi:10.1002/jmr.650 · Cited by 54 · see citing works
Nishiyama, N., Koizumi, F., Okazaki, S., Matsumura, Y., Nishio, K., & Kataoka, K. (2003) · Bioconjugate Chemistry · doi:10.1021/bc025555t · Cited by 49 · see citing works
Kossovsky, N., Gelman, A., Rajguru, S., et al. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00169-7 · Cited by 45 · see citing works
Development of a specific system for targeting protein to metallophilic macrophages
Taylor, P. R., ZAMZE, S. E., Stillion, R. J., Wong, S. Y. C., Gordon, S., & Martínez‐Pomares, L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308490100 · Cited by 45 · see citing works
Turunen, M. P., Puhakka, H. L., Koponen, J. K., et al. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0668 · Cited by 44 · see citing works
Christofidou‐Solomidou, M., Pietra, G. G., Solomides, C., Arguiris, E., Harshaw, D. W., FitzGerald, G. A., Albelda, S. Μ., & Muzykantov, V. R. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.278.4.l794 · Cited by 37 · see citing works
Mandal, M., Kawamura, K. S., Wherry, E. J., et al. (2003) · Molecular Pharmaceutics · doi:10.1021/mp034021m · Cited by 32 · see citing works
Lipid formulations of amphotericin B preserve and stabilize renal function in HSCT recipients
Miller, C. B., Waller, E. K., Klingemann, H.-G., et al. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704408 · Cited by 27 · see citing works
Cytokines in mice treated with amphotericin B-intralipid
Shadkchan, Y., Keisari, Y., & Segal, E. (2004) · Medical Mycology · doi:10.1080/13693780310001624583 · Cited by 20 · see citing works
Verderone, G., Craynest, N. V., Boussif, O., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9911579 · Cited by 20 · see citing works
Endothelial Cells as Therapeutic Targets in Cancer: New Biology and Novel Delivery Systems
Murray, J. C., & Moghimi, S. M. (2003) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v20.i23.20 · Cited by 15 · see citing works
Self-citationMurray, J., Moghimi, S., Hunter, A., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601928 · Cited by 4 · see citing works
Self-citationTsuchihashi (2000) · doi:10.1002/1521-4141(200006)30:6
Atsumi (2000) · doi:10.1002/1529-0131(200009)43:9
Flagged first, then by citations
Cited by
Sorted by citations
Nanomaterials and nanoparticles: Sources and toxicity
Buzea, C., Pacheco, I. I., & Robbie, K. (2007) · Biointerphases · doi:10.1116/1.2815690 · Cited by 3,789 · see citing works
Maeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376 · see citing works
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951 · see citing works
Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912 · see citing works
Walkey, C. D., & Chan, W. C. W. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15233e · Cited by 1,758 · see citing works
Physical approaches to biomaterial design
Mitragotri, S., & Lahann, J. (2009) · Nature Materials · doi:10.1038/nmat2344 · Cited by 1,445 · see citing works
Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems
Nasongkla, N., Bey, E., Ren, J., Ai, H., Khemtong, C., Guthi, J. S., Chin, S.-F., Sherry, A. D., Boothman, D. A., & Gao, J. (2006) · Nano Letters · doi:10.1021/nl061412u · Cited by 1,238 · see citing works
The transferrin receptor and the targeted delivery of therapeutic agents against cancer
Daniels, T. R., Bernabeu, E., Rodríguez, J. A., Patel, S., Kozman, M., Chiappetta, D. A., Holler, E., Ljubimova, J. Y., Helguera, G., & Penichet, M. L. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.07.016 · Cited by 807 · see citing works
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645 · see citing works
Polymeric nanomedicine for cancer therapy
Park, J. H., Lee, S., Kim, J.-H., Park, K., Kim, K., & Kwon, I. C. (2008) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.09.003 · Cited by 506 · see citing works
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
Lobatto, M. E., Fuster, V., Fayad, Z. A., & Mulder, W. J. M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3578 · Cited by 423 · see citing works
Drug nanocrystals: in vivo performances.
Gao, L., Liu, G., Ma, J., Wang, X., Zhou, L., & Li, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.013 · Cited by 347 · see citing works
Clinical toxicities of nanocarrier systems.
Vega-Villa, K. R., Takemoto, J. K., Yáñez, J. A., Remsberg, C. M., Forrest, M. L., & Davies, N. M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.007 · Cited by 325 · see citing works
Fahrni, C. J. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.02.039 · Cited by 297 · see citing works
Micelles structure development as a strategy to improve smart cancer therapy
Hanafy, N., El-Kemary, M., & Leporatti, S. (2018) · Cancers · doi:10.3390/cancers10070238 · Cited by 287 · see citing works
Pharmaceutical nanotechnology: from the bench to the market
Mazayen, Z. M., Ghoneim, A. M., Elbatanony, R. S., Basalious, E. B., & Bendas, E. R. (2022) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-022-00400-0 · Cited by 208 · see citing works
Fate of micelles and quantum dots in cells
Maysinger, D., Lovrić, J., Eisenberg, A., & Savić, R. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.08.011 · Cited by 160 · see citing works
PEGylated nanomedicines: recent progress and remaining concerns
Vllasaliu, D., Fowler, R., & Stolnik, S. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.866651 · Cited by 137 · see citing works
The formulation of nanomedicines for treating tuberculosis
Costa, A., Pinheiro, M., Magalhães, J., Ribeiro, R., Seabra, V., Reis, S., & Sarmento, B. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.012 · Cited by 123 · see citing works
Liu, D., Liu, F., Liu, Z., Wang, L., & Zhang, N. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200402e · Cited by 108 · see citing works
Nanoparticle-Mediated Drug Delivery System for Cardiovascular Disease
Matoba, T., & Egashira, K. (2014) · International Heart Journal · doi:10.1536/ihj.14-150 · Cited by 83 · see citing works
Li, L., Wang, J., Kong, H., Zeng, Y., & Liu, G. (2018) · Science and Technology of Advanced Materials · doi:10.1080/14686996.2018.1528850 · Cited by 71 · see citing works
Synthetic Microvascular Networks for Quantitative Analysis of Particle Adhesion
Prabhakarpandian, B., Pant, K., Scott, R. C., Patillo, C. B., Irimia, D., Kiani, M. F., & Sundaram, S. (2008) · Biomedical Microdevices · doi:10.1007/s10544-008-9170-y · Cited by 68 · see citing works
LHRH-targeted nanogels as a delivery system for cisplatin to ovarian cancer
Nukolova, N. V., Oberoi, H. S., Zhao, Y., Chekhonin, V. P., Kabanov, A. V., & Bronich, T. K. (2013) · Molecular Pharmaceutics · doi:10.1021/mp4003688 · Cited by 63 · see citing works
Montelione, N., Loreni, F., Nenna, A., Catanese, V., Scurto, L., Ferrisi, C., Jawabra, M., Gabellini, T., Codispoti, F. A., Spinelli, F., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11030798 · Cited by 30 · see citing works
Gupta, A., Kaur, C. D., Saraf, S., & Saraf, S. (2017) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2016.1147581 · Cited by 27 · see citing works
Grinberg, O., Gedanken, A., Mukhopadhyay, D., & Patra, C. R. (2013) · Polymers for Advanced Technologies · doi:10.1002/pat.3081 · Cited by 16 · see citing works
- Authors
- Moghimi, S. M., Hunter, A. C., & Murray, J. C.
- Affiliations
- University of Brighton (GB)
- Cancer Research UK (GB)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2005-03
- Volume
- 19
- Issue
- 3
- Pages
- 311-330
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2111115146
- Cited by
- 2,029
- References
- 164
- Citations by year
- 2026: 42 · 2025: 54 · 2024: 54 · 2023: 76 · 2022: 84 · 2021: 78 · 2020: 85 · 2019: 89 · 2018: 102 · 2017: 140 · 2016: 131 · 2015: 123 · 2014: 134 · 2013: 121 · 2012: 128
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- University of Brighton Repository (University of Brighton) (submittedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanotechnology research and applications
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Pharmacology and Nanomedicine Research
- Keywords
- nanomedicine, nanocarriers, targeted drug delivery, local drug delivery, nanoparticle surface modification, diagnostic imaging, dendritic cells, tumor neovasculature, mononuclear phagocytes, endothelial cells, nanoparticle toxicity, parenteral administration
- MeSH terms
- Blood Vessels, Diagnosis, Drug Administration Routes, Drug Hypersensitivity, Drug Industry, Drug Therapy, Endothelium, Vascular, Humans, Lymphatic System, Macrophages, Microscopy, Electron, Scanning, National Institutes of Health (U.S.), Neoplasms, Particle Size, Technology, Pharmaceutical, United States, Drug Delivery Systems, Nanotechnology, Nanostructures, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review